“Clusters are geographic concentrations of interconnected companies and institutions in a particular field. Clusters encompass an array of linked industries and other entities important to competition. They include, for example, suppliers of specialized inputs such as components, machinery, and services, and providers of specialized infrastructure. Clusters also often extend downstream to channels and customers and laterally to manufacturers of complementary products and to companies in industries related by skills, technologies, or common inputs. Finally, many clusters include governmental and other institutions—such as universities, standard-setting agencies, think tanks, vocational training providers, and trade associations […].”

– (Porter, M.E. (1998). “Clusters and the New Economics of Competition,” Harvard Business Review, November-December 1998.)

The LSHT cluster

Industry piloted, university driven and financed mainly by government, the cluster is a network of exchanges and information‑sharing that brings together the LSHT ecosystem in all its diversity. Montréal InVivo works hard to strengthen the growth and competitiveness of the LSHT sector through collaboration between all stakeholders.

I salute the leadership of Montreal InVivo within the life sciences ecosystem in Quebec and in Canada. Thanks to its inclusive approach, it brings together both public and private actors and influences the whole sector.

Rémi Quirion, Québec’s Chief Scientist

The industry players

All the organizations, institutions and companies active in the LSHT sector of Greater Montreal are
in fact a part of the cluster.

Research institutes

  • Universities
  • University hospital research centers
  • Research institutes in Life Science
  • Research institutes in Artificial intelligence and digital health


  • Government of Canada
  • Government of Québec
  • Montréal metropolitan community
  • City of Montréal

Funding organizations

  • Québec Health Research Fund (FRQS)
  • Canadian Institutes of Health Research (CIHR)
  • NRC / CRNC
  • Venture capital funds
  • Institutional investors
  • Private investors


  • Pharmaceutical
  • Biotechnology
  • Health technologies/medical devices (MedTech)
  • Research and contract manufacturing (CRM-CMO)
  • Health IT (including artificial intelligence in life sciences)